Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (341-350 of 511) with videos related to

Pageof 52
Sort By:
Breast Cancer Research : BCR|July 1, 2005
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot studySarah J Lord, Wendy J Mack, David Van Den Berg, et al.
The Journal of Pathology|August 12, 2016
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelSarah L Maguire, Barrie Peck, Patty T Wai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cellsSimonetta Sipione, Katia C Simmen, Sarah J Lord, et al.
Health Technology Assessment (Winchester, England)|December 12, 2013
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) projectJ Lord, S Willis, J Eatock, et al.
Thorax|April 18, 2015
The prospective evaluation of the TB strain typing service in England: a mixed methods studyJ Mears, E Vynnycky, J Lord, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 1, 1995
Mapping the diabetes polygene Idd3 on mouse chromosome 3 by use of novel congenic strainsC J Lord, S K Bohlander, E A Hopes, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 2015
Setting analytical performance specifications based on outcome studies - is it possible?Andrea Rita Horvath, Patrick M M Bossuyt, Sverre Sandberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2016
Biomarker development targeting unmet clinical needsPhillip J Monaghan, Sarah J Lord, Andrew St John, et al.
Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.
International Journal of Cancer|August 13, 2017
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage countryLouiza S Velentzis, Michael Caruana, Kate T Simms, et al.
Pageof 52

Showing results (341-350 of 511) with videos related to

Sort By:
Pageof 52
Breast Cancer Research : BCR|July 1, 2005
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot studySarah J Lord, Wendy J Mack, David Van Den Berg, et al.
The Journal of Pathology|August 12, 2016
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelSarah L Maguire, Barrie Peck, Patty T Wai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cellsSimonetta Sipione, Katia C Simmen, Sarah J Lord, et al.
Health Technology Assessment (Winchester, England)|December 12, 2013
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) projectJ Lord, S Willis, J Eatock, et al.
Thorax|April 18, 2015
The prospective evaluation of the TB strain typing service in England: a mixed methods studyJ Mears, E Vynnycky, J Lord, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 1, 1995
Mapping the diabetes polygene Idd3 on mouse chromosome 3 by use of novel congenic strainsC J Lord, S K Bohlander, E A Hopes, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 2015
Setting analytical performance specifications based on outcome studies - is it possible?Andrea Rita Horvath, Patrick M M Bossuyt, Sverre Sandberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2016
Biomarker development targeting unmet clinical needsPhillip J Monaghan, Sarah J Lord, Andrew St John, et al.
Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.
International Journal of Cancer|August 13, 2017
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage countryLouiza S Velentzis, Michael Caruana, Kate T Simms, et al.
Pageof 52